Your browser doesn't support javascript.
loading
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
Song, Yuqin; Wu, Shang-Ju; Shen, Zhixiang; Zhao, Donglu; Chan, Thomas Sau Yan; Huang, Huiqiang; Qiu, Lugui; Li, Jianyong; Tan, Tran-der; Zhu, Jun; Song, Yongping; Huang, Wei-Han; Zhao, Weili; Liu, Herman Sung Yu; Xu, Wei; Chen, Naizhi; Ma, Jun; Chang, Cheng-Shyong; Tse, Eric Wai Choi.
Afiliação
  • Song Y; Peking University Cancer Hospital and Institute, Beijing, China.
  • Wu SJ; Hematology Division, Department of Internal Medicine, National Taiwan University Hospital, Taiwan, China.
  • Shen Z; Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai, China.
  • Zhao D; Harbin Hematology and Oncology Institute, Heilongjiang, 150007, China.
  • Chan TSY; Department of Medicine, Queen Mary Hospital, Hong Kong, China.
  • Huang H; Sun Yat-Sen University Cancer Center, Guangdong, China.
  • Qiu L; Institute of Hematology and Blood Diseases Hospital, Tianjing, China.
  • Li J; Jiangsu Provincial People's Hospital, Jiangsu, China.
  • Tan TD; Department of Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan, China.
  • Zhu J; Peking University Cancer Hospital and Institute, Beijing, China.
  • Song Y; The First Affiliated Hospital of Zhengzhou University, Henan, China.
  • Huang WH; Department of Clinical Pathology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan, China.
  • Zhao W; Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai, China.
  • Liu HSY; Premier Medical Centre, Hong Kong, China.
  • Xu W; Jiangsu Provincial People's Hospital, Jiangsu, China.
  • Chen N; Macau Society of Hematology and Oncology, Macau, China.
  • Ma J; Harbin Hematology and Oncology Institute, Heilongjiang, 150007, China. majun0322@126.com.
  • Chang CS; Division of Hematology-Oncology, Department of Internal Medicine, Chang Bing Show Chwan Memorial Hospital, Taiwan, China. cs4816@gmail.com.
  • Tse EWC; Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taiwan, China. cs4816@gmail.com.
Exp Hematol Oncol ; 12(1): 92, 2023 Oct 16.
Article em En | MEDLINE | ID: mdl-37845755
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido